Global Mycotoxin Testing Industry

Global Mycotoxin Testing Industry

  • July 2020 •
  • 262 pages •
  • Report ID: 5799203 •
  • Format: PDF
Global Mycotoxin Testing Market to Reach $1.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Mycotoxin Testing estimated at US$884.9 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at aCAGR of 5% over the period 2020-2027. Chromatography
& Spectroscopy-based, one of the segments analyzed in the report, is projected to record 5.6% CAGR and reach US$771.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Immunoassay-based segment is readjusted to a revised 4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $239.7 Million, While China is Forecast to Grow at 7.7% CAGR

The Mycotoxin Testing market in the U.S. is estimated at US$239.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$257.4 Million by the year 2027 trailing a CAGR of 7.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.We bring years of research experience to this 6th edition of our report. The 262-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,
  • ALS Ltd.
  • AsureQuality Ltd.
  • Bureau Veritas SA
  • Eurofins Scientific SE
  • Intertek Group PLC
  • Microbac Laboratories, Inc.
  • Romer Labs Division Holding GmbH
  • SGS SA
  • Silliker, Inc.
  • Symbio Laboratories